HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

The European Commission has amended EU REACH chemicals law so that SMEs pay less in registration fees, while larger companies pay more. More news in brief.

You may also be interested in...



ECHA Provides Cues For Self-Assessing REACH Deadline Preparedness

As the May 31 REACH deadline approaches, dossier registrants should know their roles within SIEF registrant groups and ensure that dossiers clearly identify and characterize substances, says the European Chemicals Agency. Over 3,000 substances are expected to have been registered by June.

In Brief

FDA invites public input in preparation for the seventh meeting of national authorities under the International Cooperation on Cosmetics Regulation, while The National Toxicology Program requests information on technologies and non-animal approaches that can be used to screen compounds for potential neurotoxicity. More news in brief.

Dr. Bronner’s Joins WFTO, Takes Jab At Fair Trade USA

Dr. Bronner’s Magic Soaps joins the World Fair Trade Organization, which recognizes “fully committed” fair-trade brands, it says. The organic personal-care maker seizes the opportunity to contrast WFTO’s program with that of Fair Trade USA.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018459

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel